Pembrolizumab (pembro) in patients with advanced hepatocellular carcinoma (HCC): KEYNOTE-224 update.

@inproceedings{Zhu2018PembrolizumabI,
  title={Pembrolizumab (pembro) in patients with advanced hepatocellular carcinoma (HCC): KEYNOTE-224 update.},
  author={Andrew X. Zhu and Richard S. Finn and Julien Edeline and St{\'e}phane Cattan and Sadahisa Ogasawara and Daniel H. Palmer and Chris Verslype and Vittorina Zagonel and Laetitia Fartoux and Arndt Vogel and Debashis Sarker and G Verset and Stephen L. Chan and Jennifer J. Knox and Bruno Daniele and Scot W. Ebbinghaus and Junshui Ma and Abby B. Siegel and Ann-lii Cheng and Masatoshi Kudo},
  year={2018}
}

From This Paper

Topics from this paper.